CuteraCUTR
Market Cap: $13.8M
About: Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.
Employees: 430
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
10% less funds holding
Funds holding: 88 [Q1] → 79 (-9) [Q2]
15.2% less ownership
Funds ownership: 68.03% [Q1] → 52.84% (-15.2%) [Q2]
20% less capital invested
Capital invested by funds: $20M [Q1] → $16M (-$3.92M) [Q2]
31% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 29
48% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 31
54% less call options, than puts
Call options by funds: $424K | Put options by funds: $923K
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Stephens & Co. George Sellers 53% 1-year accuracy 9 / 17 met price target | 628%upside $5 | Overweight Maintained | 9 Aug 2024 |
Piper Sandler Matt O'Brien 50% 1-year accuracy 22 / 44 met price target | 46%upside $1 | Neutral Reiterated | 9 Aug 2024 |
Stephens & Co. George Sellers 53% 1-year accuracy 9 / 17 met price target | 1,356%upside $10 | Overweight Reiterated | 25 Jun 2024 |
Piper Sandler Matt O'Brien 50% 1-year accuracy 22 / 44 met price target | 337%upside $3 | Neutral Maintained | 21 Jun 2024 |